Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Ong, Sang-Ging  [Clear All Filters]
2024
Yan G, Han Z, Kwon Y, Jousma J, Nukala SBabu, Prosser BL, Du X, Pinho S, Ong S-B, Lee WHee, et al. Integrated Stress Response Potentiates Ponatinib-Induced Cardiotoxicity. Circ Res. 2024.
2023
Liu C-W, Le HHuong Thi, Iii PDenaro, Dai Z, Shao N-Y, Ong S-G, Lee WHee. E-cigarettes induce dysregulation of autophagy leading to endothelial dysfunction in pulmonary arterial hypertension. Stem Cells. 2023.
Nukala SBabu, Jousma J, Yan G, Han Z, Kwon Y, Cho Y, Liu C, Gagnon K, Pinho S, Rehman J, et al. Modulation of lncRNA links endothelial glycocalyx to vascular dysfunction of tyrosine kinase inhibitor. Cardiovasc Res. 2023.
2022
Jousma J, Han Z, Yan G, Nukala SBabu, Kwon Y, Le HHuong Thi, Li Y, Ong S-B, Lee WHee, Ong S-G. Alteration of the N-methyladenosine epitranscriptomic profile in synthetic phthalate-treated human induced pluripotent stem cell-derived endothelial cells. Epigenomics. 2022.
2021
Hong L, Zhang M, Ly OThao, Chen H, Sridhar A, Lambers E, Chalazan B, Youn S-W, Maienschein-Cline M, Feferman L, et al. Human induced pluripotent stem cell-derived atrial cardiomyocytes carrying an SCN5A mutation identify nitric oxide signaling as a mediator of atrial fibrillation. Stem Cell Reports. 2021.
C Y Chang A, Pardon G, Chang ACH, Wu H, Ong S-G, Eguchi A, Ancel S, Holbrook C, Ramunas J, Ribeiro AJS, et al. Increased tissue stiffness triggers contractile dysfunction and telomere shortening in dystrophic cardiomyocytes. Stem Cell Reports. 2021.
2016
Burridge PW, Li YFuga, Matsa E, Wu H, Ong S-G, Sharma A, Holmström A, Chang AC, Coronado MJ, Ebert AD, et al. Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity. Nat Med. 2016.